Article Sidebar

Download
Statistic
Read Counter : 0

Main Article Content

Abstract

Purpose: This study aimed to identify the treatment profile and the type and severity of anti-tuberculosis drug (OAT) side effects in pulmonary tuberculosis patients at Bhina Bhakti Husada Rembang Hospital. It was hypothesized that most patients would receive first-line OAT regimens and experience side effects predominantly of moderate severity.


Research Method: This study used a descriptive observational method with a cross-sectional design. Data were obtained retrospectively from the medical records of 106 patients with pulmonary tuberculosis receiving first-line OAT therapy at Bhina Bhakti Husada Rembang Hospital. The variables included patient characteristics, treatment patterns, types of OAT side effects, and severity of adverse drug reactions. Data were analyzed using univariate descriptive analysis.


Results and Discussion: Most patients were aged 41-60 years (43.4%), male (64.2%), had a body weight of 30-49 kg (61.3%), and underwent treatment for 1-3 months (42.5%). The most common regimen was category 1 RHZE 2 FDC (39.6%). The most frequent side effects were reddish urine (100.0%), nausea and vomiting (83.0%), and flu syndrome (70.8%). Most side effects were categorized as moderate (56.6%).


Implications: The findings emphasize the importance of routine monitoring and early management of OAT side effects, particularly during the early treatment phase. Further studies are needed to examine risk factors associated with severe adverse reactions and their impact on treatment adherence.

Keywords

pulmonary tuberculosis anti-tuberculosis drugs adverse drug reactions side effects severity treatment profile pharmacovigilance

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
Wulandari, N. S., Setyowati, E., & Rosnarita, I. A. (2026). Medication Profile and Side Effect - Severity of Anti-Tuberculosis Drugs in Pulmonary Tuberculosis Patient at Bhina Bhakti Husada Rembang Hospital. Advances in Healthcare Research, 4(1). https://doi.org/10.60079/ahr.v4i1.714
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Agus Khoirul Anam1, Sri Winarni2, A. S. (2023). Complaints of Tuberculosis Patients About Side Effects of Anti-Tuberculosis Drugs and Factors Affecting Them at the Blitar City Health Uptd. 3(2).
  2. Azis. (2024). The Role of Thoracic X-rays in Pulmonary Tuberculosis Screening. Copyright © 2019 Bali. https://wartabalionline.com/2024/01/10/peran-foto-rontgen-toraks-dalam-skrining-tuberkulosis-paru/
  3. Azkia, N., Nur Indira, Z., Fauzi, H., & Budi Lestari, U. (2024). Analysis of Diagnosis of Pulmonary Tuberculosis in Inpatients in November 2023 at Banyumas Hospital. Journal of Medical Records and Health Information, 5(3), 234–242. https://doi.org/10.25047/j-remi.v5i3.4718
  4. BPS. (2024). Disease Cases by Regency/City and Type of Disease in Central Java Province, 2023. 2023. https://jateng.bps.go.id/id/statistics-table/3/YTA1Q1ptRmhUMEpXWTBsQmQyZzBjVzgwUzB4aVp6MDkjMw%3D%3D/kasus-penyakit-menurut-kabupaten-kota-dan-jenis-penyakit-di-provinsi-jawa-tengah--2023.html?year=2023&utm
  5. Fortuna, T. A., Rachmawati, H., Hasmono, D., & Karuniawati, H. (2022). Study of Continuation Phase Anti Tuberculosis Drugs (OAT) in New Patient with Smear-Positive. 19(1).
  6. Ministry of Health of the Republic of Indonesia. (2020a). National Guidelines for Medical Services for Tuberculosis Management.
  7. Ministry of Health of the Republic of Indonesia. (2020b). National Guidelines for Tuberculosis Management Medical Services.
  8. Ministry of Health of the Republic of Indonesia. (2025a). A book on the combination of medical personnel and tuberculosis health workers.
  9. Ministry of Health of the Republic of Indonesia. (2025b). The Indonesian Movement to End TB. 2025. https://kemkes.go.id/id/indonesias-movement-to-end-tb
  10. Laíse, E. T. (2022). Risk factors associated with adverse reactions to antituberculosis drugs. J Bras Pneumologia, 41, 77–89. https://doi.org/10.1590/S1806-37132015000100010
  11. Nasichah, S. N. A., & Kristinawati, B. (2024). The Relationship of Side Effects of Anti-Tuberculosis Drugs and Comorbidities with the Quality of Life of Pulmonary Tuberculosis Patients. Journal of Telenursing (JOTING), 6(1), 104–112. https://journal.ipm2kpe.or.id/index.php/JOTING/article/view/8565
  12. Nirahua, J. B., Pandapotan, R. A., Layanto, N., Health, I., Kristen, U., Discourse, K., Dalam, I. P., Medicine, F., Christian, U., Discourse, K., Microbiology, D., Medicine, F., & Krida, U. K. (2021). Successful Pulmonary Tuberculosis Treatment with Comorbid Diabetes Mellitus Type 2. Journal of Clinical Medicine, 27(3), 289–296. http://ejournal.ukrida.ac.id/ojs/index.php/Meditek/article/view/2007/2080
  13. Nurhikma, E., Bina, P., Kendari, H., & Pharmacy, P. D. (2021). SIDE EFFECTS OF ANTI-TUBERCULOSIS DRUGS (OATS) AND THEIR TREATMENT IN TUBERCULOSIS (TB) PATIENTS IN 4(1), 67–73.
  14. Oliviera, I., Kholis, F. N., & Ngestiningsih, D. (2020). Patterns of Comorbid Disease Incidence and Side Effects. Journal of Diponegoro Medicine, 5(4), 1081–1091.
  15. Rosnarita, I. A. (2025). Research Methodology: Concept, Design, and Data Analysis. 1, 348. https://scholar.google.com/citations?view_op=view_citation&hl=id&user=zoet2_UAAAAJ&sortby=title&citation_for_view=zoet2_UAAAAJ:Se3iqnhoufwC
  16. Ruben, S. D., Tondok, S. B., & Suprayitno, G. (2023). Correlation of Side Effects of Anti-Tuberculosis Drugs with Treatment Compliance of Pulmonary TB Patients. Journal of Pharmaceutical and Health Research, 4(3), 413–420. https://doi.org/10.47065/jharma.v4i3.3670
  17. Setyowati, E., Mila, E., Prayitno, F., Mundriyastutik, Y., & Isnaeni, D. (2021). COMPARISON OF THE EFFECTIVENESS OF BLOOD PRESSURE MEDICATION WITH THE COMBINATION OF AMLODIPINE WITH CAPTOPRIL AND AMLODIPINE WITH LISINOPRIL IN PATIENTS WITH HYPERTENSION. 6(2), 40–49.
  18. Verencia, A., Rizki, G., & Farizi, A. (2021). Study of Anti Tuberculosis Drugs Used In Pulmonary Tuberculosis Patients.
  19. Yati, D., Agustin, R., & Wulanningrum, D. N. (2023). Overview of Drug Side Effects (ESO) in Tuberculosis Patients in the Working Area of the Jatiroto Health Center, Wonogiri Regency. Thesis, 1–10.